Showing results (1021-1030 of 5,919) with videos related to

Sort By:
Pageof 592
Arthritis Research & Therapy|March 5, 2013
The severity of experimental arthritis is independent of IL-36 receptor signalingCéline Lamacchia, Gaby Palmer, Emiliana Rodriguez, et al.
Arthritis Research & Therapy|April 16, 2013
microRNA-mediated regulation of innate immune response in rheumatic diseasesXiaobing Luo, Koustubh Ranade, Ronel Talker, et al.
Arthritis Research & Therapy|January 31, 2013
Intra-articular delivery of adipose derived stromal cells attenuates osteoarthritis progression in an experimental rabbit modelGiovanna Desando, Carola Cavallo, Federica Sartoni, et al.
Arthritis Research & Therapy|September 6, 2013
Revisiting spatial distribution and biochemical composition of calcium-containing crystals in human osteoarthritic articular cartilageChristelle Nguyen, Dominique Bazin, Michel Daudon, et al.
Arthritis Research & Therapy|September 7, 2013
Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis--a prospective case-series studyOrsolya Timár, Zoltán Szekanecz, György Kerekes, et al.
Arthritis Research & Therapy|September 11, 2013
Clinical correlations with Porphyromonas gingivalis antibody responses in patients with early rheumatoid arthritisSheila L Arvikar, Deborah S Collier, Mark C Fisher, et al.
Arthritis Research & Therapy|July 18, 2014
Targeting of viral interleukin-10 with an antibody fragment specific to damaged arthritic cartilage improves its therapeutic potencyChris Hughes, Angelica Sette, Michael Seed, et al.
Arthritis Research & Therapy|July 27, 2014
Changes in serum creatinine in patients with active rheumatoid arthritis treated with tofacitinib: results from clinical trialsJohn D Isaacs, Andrea Zuckerman, Sriram Krishnaswami, et al.
Arthritis Research & Therapy|July 31, 2014
Adalimumab serum levels and antidrug antibodies towards adalimumab in peripheral spondyloarthritis: no association with clinical response to treatment or with disease relapse upon treatment discontinuationJacqueline E Paramarta, Dominique L Baeten
Arthritis Research & Therapy|July 30, 2013
The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patientsChamaida Plasencia, Dora Pascual-Salcedo, Sara García-Carazo, et al.
Pageof 592